Chris Walker

1.6k total citations
22 papers, 628 citations indexed

About

Chris Walker is a scholar working on Pharmacology, Rheumatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chris Walker has authored 22 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Rheumatology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chris Walker's work include Inflammatory mediators and NSAID effects (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Chris Walker is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Chris Walker collaborates with scholars based in United States, United Kingdom and Spain. Chris Walker's co-authors include Francis Bérenbaum, Luigi M. Biasucci, Trisha Suppes, Margaret Minkwitz, Denis F. Darko, Catherine Datto, A. Nordenhem, Duo Zhou, Ana Gordo and Eric Van Cutsem and has published in prestigious journals such as Blood, Cancer and International Journal of Cancer.

In The Last Decade

Chris Walker

22 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Walker United States	13	175	164	142	138	88	22	628
Chen Su China	13	106 0.6×	25 0.2×	32 0.2×	49 0.4×	181 2.1×	47	539
Masashi Ukai Japan	14	82 0.5×	31 0.2×	277 2.0×	34 0.2×	129 1.5×	30	792
Tomoko Yamada Japan	11	51 0.3×	28 0.2×	63 0.4×	49 0.4×	70 0.8×	34	439
Albino Bonazzi Italy	13	168 1.0×	24 0.1×	25 0.2×	60 0.4×	191 2.2×	21	637
Eunice Yuen United States	18	63 0.4×	97 0.6×	11 0.1×	211 1.5×	320 3.6×	47	872
Francisco Ruíz-Espejo Spain	14	166 0.9×	20 0.1×	52 0.4×	34 0.2×	284 3.2×	27	639
Fangfang Zhang China	12	48 0.3×	29 0.2×	19 0.1×	91 0.7×	168 1.9×	24	588
Ryan T. Dackor United States	17	79 0.5×	54 0.3×	11 0.1×	79 0.6×	297 3.4×	18	861
Arianna Bettiga Italy	16	129 0.7×	14 0.1×	26 0.2×	58 0.4×	240 2.7×	38	624

Countries citing papers authored by Chris Walker

Since Specialization

Citations

This map shows the geographic impact of Chris Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Walker more than expected).

Fields of papers citing papers by Chris Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Walker. The network helps show where Chris Walker may publish in the future.

Co-authorship network of co-authors of Chris Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Walker. A scholar is included among the top collaborators of Chris Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Walker. Chris Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harding, James J., Christiane Jungels, Jean‐Pascal Machiels, et al.. (2023). First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors. Targeted Oncology. 18(2). 181–193. 7 indexed citations

Patel, Manish R., William B. Donnellan, Michael Byrne, et al.. (2023). Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies. Clinical Lymphoma Myeloma & Leukemia. 23(9). 674–686. 4 indexed citations

Libby, Peter, M. Elaine Husni, Qiuqing Wang, et al.. (2022). Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial. European Heart Journal - Cardiovascular Pharmacotherapy. 8(6). 611–621. 22 indexed citations

Naing, Aung, Alain P. Algazi, Gerald S. Falchook, et al.. (2022). Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors. Cancer. 129(1). 71–81. 15 indexed citations

Gotlib, Jason, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, et al.. (2021). A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1). Blood. 138(Supplement 1). 385–385. 29 indexed citations

Chirikov, Viktor, Chris Walker, Jennifer Stephens, et al.. (2021). Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial. ClinicoEconomics and Outcomes Research. Volume 13. 409–420. 5 indexed citations

Bérenbaum, Francis & Chris Walker. (2020). Osteoarthritis and inflammation: a serious disease with overlapping phenotypic patterns. Postgraduate Medicine. 132(4). 377–384. 77 indexed citations

Hellmann, Matthew D., Scott Gettinger, Laura Q.M. Chow, et al.. (2020). Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer. International Journal of Cancer. 147(7). 1963–1969. 33 indexed citations

Yeomans, Neville D., David Y. Graham, M. Elaine Husni, et al.. (2018). Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Alimentary Pharmacology & Therapeutics. 47(11). 1453–1463. 35 indexed citations

10.

Hurwitz, Herbert I., Eric Van Cutsem, Johanna C. Bendell, et al.. (2018). Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies. Investigational New Drugs. 36(4). 683–695. 87 indexed citations

11.

Shelbaya, Ahmed, et al.. (2018). The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis. ClinicoEconomics and Outcomes Research. Volume 10. 213–222. 8 indexed citations

12.

Lubis, Andri Maruli Tua, et al.. (2017). Comparing the Safety and Efficacy of Celecoxib for the Treatment of Osteoarthritis in Asian and non-Asian Populations: An Analysis of Data from Two Randomized, Double-blind, Placebo-controlled, Active-comparator Trials. Pain and Therapy. 6(2). 235–242. 2 indexed citations

13.

Walker, Chris & Luigi M. Biasucci. (2017). Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited. Postgraduate Medicine. 130(1). 55–71. 45 indexed citations

14.

Walker, Chris, Margaret Noyes Essex, Chunming Li, & Peter W. Park. (2016). Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients. Journal of International Medical Research. 44(3). 483–495. 17 indexed citations

15.

Ji, Xiaomeng, Caitlyn T. Solem, Ahmed Shelbaya, et al.. (2015). Generic Switch Evaluation of Celebrex® In Patients With Osteoarthritis (OA) Using A Retrospective Claims Database. Value in Health. 18(3). A158–A158. 1 indexed citations

16.

Walker, Chris, Augusto Faustino, & Ángel Lanas. (2014). Monitoring Complete Blood Counts and Haemoglobin Levels in Osteoarthritis Patients: Results from a European Survey Investigating Primary Care Physician Behaviours and Understanding. The Open Rheumatology Journal. 8(1). 110–115. 3 indexed citations

17.

Suppes, Trisha, Catherine Datto, Margaret Minkwitz, et al.. (2009). Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. Journal of Affective Disorders. 121(1-2). 106–115. 126 indexed citations

18.

Lim, Aaron G., Chris Walker, S. Chambers, & S R Gould. (1997). Helicobacter pylori eradication using a 7‐day regimen of low‐dose clarithromycin, lansoprazole and amoxycillin. Alimentary Pharmacology & Therapeutics. 11(3). 537–540. 10 indexed citations

19.

Walker, Chris, et al.. (1997). Development of a Novel TNFα Ligand-Receptor Binding Assay for Screening Natchem^TMLibraries. Journal of Receptors and Signal Transduction. 17(1-3). 521–529. 4 indexed citations

20.

Walker, Chris. (1959). Migraine and its Relationship to Hypertension. BMJ. 2(5164). 1430–1433. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact